Singapore markets closed

Mersana Therapeutics, Inc. (MRSN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.6200-0.0900 (-3.32%)
As of 10:47AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-171,670
-171,670
-204,212
-170,060
-88,045
Depreciation & amortisation
1,517
1,517
927
855
1,010
Stock-based compensation
21,136
21,136
21,522
18,409
7,172
Change in working capital
-18,763
-18,763
130,322
10,085
5,105
Accounts receivable
30,000
30,000
-30,000
0
0
Accounts payable
-6,080
-6,080
947
483
942
Other working capital
-171,050
-171,050
-51,560
-140,636
-75,169
Other non-cash items
3,467
3,467
3,540
723
148
Net cash provided by operating activities
-168,882
-168,882
-49,363
-139,988
-74,696
Cash flows from investing activities
Investments in property, plant and equipment
-2,168
-2,168
-2,197
-648
-473
Purchases of investments
-155,919
-155,919
-247,519
0
0
Sales/maturities of investments
277,970
277,970
97,000
0
37,500
Net cash used for investing activities
119,883
119,883
-152,716
-648
37,027
Cash flows from financing activities
Debt repayment
-412
-412
-272
-5,701
-313
Common stock issued
93,539
93,539
150,893
43,087
227,026
Other financing activities
-
-
-
-259
-
Net cash used provided by (used for) financing activities
94,675
94,675
153,017
63,646
230,412
Net change in cash
45,676
45,676
-49,062
-76,990
192,743
Cash at beginning of period
129,363
129,363
178,425
255,415
62,672
Cash at end of period
175,039
175,039
129,363
178,425
255,415
Free cash flow
Operating cash flow
-168,882
-168,882
-49,363
-139,988
-74,696
Capital expenditure
-2,168
-2,168
-2,197
-648
-473
Free cash flow
-171,050
-171,050
-51,560
-140,636
-75,169